M. Alexander Otto
Study calls higher surgery costs at NCI centers into question
September 1, 2021
When is the higher cost of cancer surgery at NCI centers worth it?
Even patients with cancer in remission at risk for severe COVID-19
January 26, 2021
Cancer patients, regardless of their age, and even if they are in remission, should be prioritized for vaccination against COVID-19.
A 4-point thrombocytopenia score was found able to rule out suspected HIT
January 11, 2021
A low score – 3 points or less – has a negative predictive value of 99.8%, “so HIT is basically ruled out.”
Cost is the main hurdle to broad use of caplacizumab for TTP
December 7, 2020
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said.
What to do when anticoagulation fails cancer patients
December 1, 2020
When it comes to “anticoagulation failure, we are entering an evidence free-zone.”
COVID-19 in pregnancy: Supplement oxygen if saturation dips below 94%
May 8, 2020
Use high-flow nasal cannula, not positive-pressure ventilation.
Results from 11 AHA-funded COVID-19 studies expected within months
May 7, 2020
The AHA’s COVID-19 and Its Cardiovascular Impact Rapid Response Grant initiative awards $1.2 million in grants.
Case series suggests biologics, JAK inhibitors safe during pandemic
May 1, 2020
Investigators saw no increase in hospitalizations versus the general population in New York City.
Yale’s COVID-19 inpatient protocol: Hydroxychloroquine plus/minus tocilizumab
April 30, 2020
Yale cardiologist offers lessons from “the haze of battle” on fighting COVID-19 with little evidence.
Protean manifestations of COVID-19: “Our ignorance is profound”
April 17, 2020
“Make sure they didn’t die in vain.”